Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
7076
Inseego
INSG
$81.1M
| $930K | ﹤0.01% |
44,927
-10,134
| -18% | -$245K |
2020 Q4
7 quarters
|
|
7077
CALL
Invesco WilderHill Clean Energy ETF
PBW
$344M
| $930K | ﹤0.01% |
19,300
+1,700
| +10% | +$92.6K |
2020 Q1
10 quarters
|
|
7078
PUT
Alpha and Omega Semiconductor
AOSL
$916M
| $929K | ﹤0.01% |
30,200
-23,500
| -44% | -$870K |
2021 Q1
6 quarters
|
|
|
DVAX
7079
CALL
DELISTED
Dynavax Technologies
DVAX
| $929K | ﹤0.01% |
89,000
-44,300
| -33% | -$577K |
2013 Q2
37 quarters
|
|
7080
PUT
Ionis Pharmaceuticals
IONS
$7.24B
| $929K | ﹤0.01% |
21,000
+1,200
| +6% | +$50.6K |
2016 Q1
26 quarters
|
|
7081
CALL
St. Joe Company
JOE
$3.72B
| $929K | ﹤0.01% |
29,000
-22,300
| -43% | -$864K |
2018 Q3
16 quarters
|
|
7082
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$77.7M
| $929K | ﹤0.01% |
12,419
+2,099
| +20% | +$169K |
2022 Q1
2 quarters
|
|
7083
PUT
Qfin Holdings
QFIN
$785M
| $928K | ﹤0.01% |
72,400
-23,700
| -25% | -$345K |
2021 Q1
6 quarters
|
|
|
SII
7084
PUT
Sprott
SII
$2.99B
| $928K | ﹤0.01% |
27,700
+6,400
| +30% | +$229K |
2020 Q4
7 quarters
|
|
7085
PUT
Sportradar
SRAD
$3.48B
| $928K | ﹤0.01% |
105,400
+93,200
| +764% | +$929K |
2022 Q2
1 quarter
|
|
|
QUOT
7086
DELISTED
Quotient Technology Inc
QUOT
| $928K | ﹤0.01% |
401,730
-161,314
| -29% | -$396K |
2019 Q3
12 quarters
|
|
7087
CALL
AerSale
ASLE
$241M
| $927K | ﹤0.01% |
50,000
-19,000
| -28% | -$351K |
2021 Q3
4 quarters
|
|
7088
Aspen Aerogels
ASPN
$472M
| $927K | ﹤0.01% |
100,500
+44,911
| +81% | +$544K |
2020 Q4
7 quarters
|
|
|
PTRA
7089
DELISTED
Proterra Inc. Common Stock
PTRA
| $927K | ﹤0.01% |
186,105
+84,604
| +83% | +$474K |
2020 Q4
7 quarters
|
|
7090
GraniteShares Nasdaq Select Disruptors ETF
DRUP
$49.7M
| $926K | ﹤0.01% |
29,277
+15,590
| +114% | +$548K |
2022 Q1
2 quarters
|
|
|
TUYA
7091
Tuya Inc
TUYA
$1.04B
| $926K | ﹤0.01% |
996,479
+667,222
| +203% | +$1.07M |
2021 Q1
6 quarters
|
|
7092
Zillow
ZG
$6.32B
| $926K | ﹤0.01% |
32,331
-164,423
| -84% | -$5.73M |
2021 Q1
6 quarters
|
|
7093
ACM Research
ACMR
$5.81B
| $925K | ﹤0.01% |
+74,237
| New | +$1.21M |
2022 Q3
0 quarters
|
|
7094
Jack Henry & Associates
JKHY
$9.99B
| $925K | ﹤0.01% |
5,077
+178
| +4% | +$34.9K |
2019 Q2
13 quarters
|
|
7095
Accuray
ARAY
$33.6M
| $924K | ﹤0.01% |
444,173
-156,542
| -26% | -$356K |
2022 Q2
1 quarter
|
|
7096
Calidi Biotherapeutics
CLDI
$2.79M
| $924K | ﹤0.01% |
+49
| New | +$940K |
2022 Q3
0 quarters
|
|
7097
PUT
Emcor
EME
$34.7B
| $924K | ﹤0.01% |
8,000
-7,200
| -47% | -$823K |
2020 Q4
7 quarters
|
|
|
RNAM
7098
CALL
DELISTED
Avidity Biosciences
RNAM
| $923K | ﹤0.01% |
56,500
-121,700
| -68% | -$2.33M |
2022 Q1
2 quarters
|
|
|
Y
7099
PUT
DELISTED
Alleghany Corp
Y
| $923K | ﹤0.01% |
1,100
+300
| +38% | +$252K |
2020 Q4
7 quarters
|
|
7100
ProShares Ultra Financials
UYG
$706M
| $922K | ﹤0.01% |
24,268
+4,177
| +21% | +$196K |
2021 Q4
3 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.